Triasima Portfolio Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,693
| Closed | -$490K | – | 159 |
|
|
2024
Q4 | $490K | Sell |
5,693
-27,281
| -83% | -$2.35M | 0.1% | 118 |
|
|
2024
Q3 | $3.93M | Sell |
32,974
-29,798
| -47% | -$3.55M | 0.88% | 40 |
|
|
2024
Q2 | $8.96M | Sell |
62,772
-69
| -0.1% | -$9.85K | 0.82% | 31 |
|
|
2024
Q1 | $8.07M | Sell |
62,841
-3,427
| -5% | -$440K | 0.68% | 34 |
|
|
2023
Q4 | $6.86M | Sell |
66,268
-2,176
| -3% | -$225K | 0.57% | 36 |
|
|
2023
Q3 | $6.22M | Sell |
68,444
-908
| -1% | -$82.6K | 0.57% | 35 |
|
|
2023
Q2 | $7.43M | Sell |
69,352
-3,152
| -4% | -$338K | 0.47% | 43 |
|
|
2023
Q1 | $5.77M | Buy |
72,504
+3,316
| +5% | +$264K | 0.48% | 39 |
|
|
2022
Q4 | $4.68M | Sell |
69,188
-4,898
| -7% | -$331K | 0.36% | 51 |
|
|
2022
Q3 | $3.69M | Sell |
74,086
-27,770
| -27% | -$1.38M | 0.3% | 52 |
|
|
2022
Q2 | $5.68M | Sell |
101,856
-2,160
| -2% | -$120K | 0.4% | 40 |
|
|
2022
Q1 | $5.78M | Sell |
104,016
-3,060
| -3% | -$170K | 0.28% | 45 |
|
|
2021
Q4 | $6M | Buy |
107,076
+7,980
| +8% | +$447K | 0.29% | 45 |
|
|
2021
Q3 | $4.76M | Buy |
99,096
+21,316
| +27% | +$1.02M | 0.25% | 50 |
|
|
2021
Q2 | $3.26M | Buy |
77,780
+35,200
| +83% | +$1.47M | 0.16% | 61 |
|
|
2021
Q1 | $1.44M | Buy |
42,580
+15,000
| +54% | +$506K | 0.07% | 109 |
|
|
2020
Q4 | $963K | Buy |
+27,580
| New | +$963K | 0.05% | 111 |
|